X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1396) 1396
Book Review (158) 158
Publication (49) 49
Book Chapter (14) 14
Conference Proceeding (14) 14
Dissertation (9) 9
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cilostazol (1313) 1313
index medicus (904) 904
humans (644) 644
male (515) 515
female (323) 323
animals (309) 309
tetrazoles - therapeutic use (291) 291
pharmacology & pharmacy (281) 281
tetrazoles - pharmacology (281) 281
aged (255) 255
middle aged (248) 248
peripheral vascular disease (229) 229
intermittent claudication (220) 220
treatment outcome (211) 211
platelet aggregation inhibitors - therapeutic use (202) 202
aspirin (201) 201
cardiac & cardiovascular systems (200) 200
clopidogrel (163) 163
tetrazoles - administration & dosage (149) 149
rats (141) 141
stroke (133) 133
risk factors (124) 124
neurosciences (122) 122
drug therapy, combination (112) 112
mice (109) 109
time factors (107) 107
ticlopidine - analogs & derivatives (104) 104
analysis (100) 100
restenosis (100) 100
adult (99) 99
percutaneous coronary intervention (97) 97
platelet aggregation inhibitors - administration & dosage (97) 97
tetrazoles - adverse effects (96) 96
prevention (92) 92
platelet aggregation inhibitors - pharmacology (91) 91
atherosclerosis (89) 89
care and treatment (88) 88
stents (88) 88
aged, 80 and over (86) 86
drug therapy (86) 86
surgery (86) 86
disease models, animal (85) 85
ischemia (85) 85
platelet aggregation inhibitors - adverse effects (84) 84
phosphodiesterase inhibitor (83) 83
activation (82) 82
therapy (82) 82
clinical neurology (81) 81
peripheral arterial disease (81) 81
phosphodiesterase inhibitors - pharmacology (80) 80
intermittent claudication - drug therapy (79) 79
medicine & public health (78) 78
aspirin - therapeutic use (77) 77
disease (74) 74
double-blind (74) 74
cardiovascular (73) 73
double-blind method (71) 71
antiplatelet therapy (69) 69
inhibition (69) 69
prospective studies (69) 69
expression (68) 68
vasodilator agents - therapeutic use (68) 68
dose-response relationship, drug (67) 67
abridged index medicus (65) 65
ticlopidine (65) 65
trial (65) 65
metaanalysis (64) 64
multicenter (64) 64
ticlopidine - therapeutic use (64) 64
hematology (63) 63
platelet aggregation - drug effects (63) 63
thrombosis (63) 63
inhibitor (62) 62
medicine, research & experimental (62) 62
phosphodiesterase (62) 62
cells (61) 61
medicine, general & internal (61) 61
pentoxifylline (61) 61
oxidative stress (60) 60
diabetes (59) 59
myocardial-infarction (59) 59
peripheral arterial-disease (59) 59
endothelial-cells (58) 58
internal medicine (58) 58
inflammation (55) 55
rats, sprague-dawley (55) 55
retrospective studies (55) 55
administration, oral (54) 54
phosphodiesterase 3 inhibitors - pharmacology (54) 54
risk (53) 53
dual antiplatelet therapy (52) 52
neurology (52) 52
secondary prevention (52) 52
ticlopidine - administration & dosage (52) 52
cardiology (51) 51
phosphodiesterase inhibitors - therapeutic use (51) 51
walking (51) 51
follow-up studies (50) 50
research (50) 50
tetrazoles - pharmacokinetics (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1313) 1313
Japanese (44) 44
Korean (26) 26
German (19) 19
Spanish (7) 7
Chinese (4) 4
Hungarian (3) 3
Portuguese (3) 3
Turkish (2) 2
Czech (1) 1
Polish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


06/2011
Aim: Garlic is available as an over-the-counter herbal supplement and is known to have antiplatelet properties. Because of scarcity of clinical data regarding... 
garlic | Cilostazol | platelet aggregation
Web Resource
International Journal of Pharmaceutics, ISSN 0378-5173, 03/2019, Volume 558, pp. 284 - 290
Commercially available cilostazol (CIL) tablet releases drug immediately and is given twice a day as an antiplatelet and vasodilatory agent. However, clinical... 
Poorly water-soluble drug | Patient centricity | Binary polymeric blend | Cilostazol | Surfactant-driven modulation | Enhanced dissolution | Double controlled-release matrix tablet | DRUG-DELIVERY | DICLOFENAC | GRANULATION | FORMULATION | ORAL ABSORPTION | DISSOLUTION | CARBOPOL | MATRICES | PHARMACOLOGY & PHARMACY | IMAGING NIR-CI | HPMC | Cilostazol - administration & dosage | Polymers - administration & dosage | Vasodilator Agents - pharmacokinetics | Surface-Active Agents - pharmacokinetics | Biological Availability | Delayed-Action Preparations - chemistry | Delayed-Action Preparations - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Cilostazol - chemistry | Cilostazol - pharmacokinetics | Delayed-Action Preparations - pharmacokinetics | Platelet Aggregation Inhibitors - pharmacokinetics | Sodium Dodecyl Sulfate - administration & dosage | Sodium Dodecyl Sulfate - pharmacokinetics | Solubility | Animals | Surface-Active Agents - administration & dosage | Sodium Dodecyl Sulfate - chemistry | Dogs | Platelet Aggregation Inhibitors - chemistry | Polymers - pharmacokinetics | Drug Liberation | Polymers - chemistry | Vasodilator Agents - chemistry | Surface-Active Agents - chemistry | Vasodilator Agents - administration & dosage | Hydrogen-Ion Concentration | Surface active agents | Vasodilators | Pharmacy | Drugstores | Polymers | Hydrogen-ion concentration | Sulfates
Journal Article
Asian Journal of Pharmaceutical and Clinical Research, ISSN 0974-2441, 01/2017, Volume 10, Issue 1, pp. 1 - 2
Journal Article
Journal of Veterinary Medical Science, ISSN 0916-7250, 2017
Sick sinus syndrome (SSS) is a type of bradyarrhythmia that can lead to syncope. Cilostazol has been reported to be an effective treatment for human patients... 
cilostazol | canine | sick sinus syndrome
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2011, Volume 57, Issue 3, pp. 290 - 291
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 2/2018, Volume 35, Issue 2, pp. 1 - 20
The study discusses the value of electrospun cilostazol-loaded (CIL) polymer structures for potential vascular implant applications.Biodegradable... 
Biochemistry, general | Biomedical Engineering | tissue regeneration | Biomedicine | electrospinning | Pharmacy | polycaprolactone | cilostazol | Medical Law | drug delivery system | Pharmacology/Toxicology | POLYCAPROLACTONE NANOFIBERS | CONTROLLED-RELEASE | DIAMETER VASCULAR GRAFTS | MECHANICAL-PROPERTIES | CHEMISTRY, MULTIDISCIPLINARY | DISSOLUTION PROFILES | CURRENT STRATEGIES | PHYSICOCHEMICAL CHARACTERIZATION | POLYMER NANOFIBERS | ELASTIC-MODULUS | PHARMACOLOGY & PHARMACY | EXTRACELLULAR-MATRIX | Cilostazol - administration & dosage | Atherosclerosis - surgery | Drug Compounding - methods | Humans | Blood Vessel Prosthesis | Drug Delivery Systems | Polyesters - chemistry | Blood Vessel Prosthesis Implantation - adverse effects | Thrombosis - etiology | Platelet Aggregation Inhibitors - administration & dosage | Cilostazol - pharmacokinetics | Drug Liberation | Platelet Aggregation Inhibitors - pharmacokinetics | Thrombosis - prevention & control | Drugs | Drug delivery systems | Raman spectroscopy | Vehicles | Biodegradation | Formulations | Raman spectra | Differential scanning calorimetry | Spectroscopy | Infrared spectroscopy | Fourier transformation | Biodegradability | X-ray diffraction | Electrospinning | Mechanical properties | Modulus of elasticity | Drug delivery | Fibers | Spectrum analysis | Calorimetry | Polymers | Polycaprolactone | Index Medicus | Research Paper
Journal Article
Acta Cirurgica Brasileira, ISSN 0102-8650, 04/2018, Volume 33, Issue 4, pp. 296 - 305
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 11/2018, Volume 74, Issue 11, pp. 1417 - 1426
Journal Article
Immunopharmacology and Immunotoxicology, ISSN 0892-3973, 03/2019, Volume 41, Issue 2, pp. 179 - 184
Objectives: Pravastatin and cilostazol are used as lipid-lowering and antiplatelet agents, respectively. Regarding their well-known anti-inflammatory effects,... 
cilostazol | combination therapy | Pravastatin | inflammation | TNF | mice
Journal Article
脳卒中の外科, ISSN 0914-5508, 2017, Volume 45, Issue 1, pp. 14 - 18
The development of shunt-dependent hydrocephalus is a well-known complication of aneurysmal subarachnoid hemorrhage (SAH). Cilostazol is known to prevent the... 
hydrocephalus | cilostazol | subarachnoid hemorrhage
Journal Article
CLINICAL TOXICOLOGY, ISSN 1556-3650, 2017, Volume 55, Issue 7, pp. 771 - 772
Conference Proceeding
Journal Article
BMC Neurology, ISSN 1471-2377, 12/2017, Volume 17, Issue 1
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 12/2010, Volume 161, Issue 8, pp. 1899 - 1912
Journal Article
Thrombosis Research, ISSN 0049-3848, 12/2018, Volume 172, pp. 14 - 20
Journal Article
Journal Article
Circulation Journal, ISSN 1346-9843, 2018, Volume 82, Issue 6, pp. 1517 - 1525
Background:Patients with reduced-function CYP2C19 genotypes on dual antiplatelet therapy (DAPT) with aspirin and clopidogrel show higher clinical risk for... 
Antiplatelet therapy | Cilostazol | Platelet aggregation | Acute myocardial infarction | CYP2C19
Journal Article
Behavioural Pharmacology, ISSN 0955-8810, 02/2018, Volume 29, Issue 1, pp. 28 - 40
Journal Article
Brain Research, ISSN 0006-8993, 07/2019, Volume 1715, pp. 182 - 187
Diabetes is a global public health crisis worldwide, particularly in developing countries. Diabetes is characterized by a consistent elevation in blood glucose... 
Cilostazol | Diabetes | Maze | Memory | Hippocampus | COGNITIVE DYSFUNCTION | DEPENDENT MEMORY | NEUROSCIENCES | BRAIN | IMPAIRMENT | DECLINE
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.